The Business Research Company’s market reports offer an in-depth analysis on the market’s growth potential, major drivers, key trends and more.

The venous thromboembolism (VTE) market has witnessed a steady surge, escalating from $2.33 billion in 2023 to an estimated $2.44 billion in 2024, reflecting a Compound Annual Growth Rate (CAGR) of 4.8%. This growth is attributed to factors such as an aging population, advancements in anticoagulants, favorable reimbursement policies, and increased investments.

Anticipated Growth Trajectory

Projected Steady Growth

The venous thromboembolism (VTE) market is poised for sustained growth, with projections indicating an expansion to $2.87 billion by 2028, fueled by a CAGR of 4.2%. The forecasted growth is driven by factors including global healthcare access, genetic risk assessment, the integration of telemedicine, and a strong emphasis on patient education and support.

Growing Number Of Orthopedic Procedures

Orthopedic Procedures Driving Demand

The escalating number of orthopedic procedures is anticipated to be a key driver for the venous thromboembolism market. Orthopedic procedures, including total knee arthroplasty (TKA) and total hip arthroplasty (THA), pose a high risk of VTE. Consequently, the adoption of compression devices for Deep Vein Thrombosis (DVT) prophylaxis has surged, contributing to the market’s growth.

Statistical Insights

Research from the National Library of Medicine indicates a substantial increase in total hip arthroplasty (THA) and total knee arthroplasty (TKA) procedures. By 2040, THA and TKA procedures are expected to increase by 719,364 and 1,222,988, respectively. This surge in orthopedic procedures underscores the growing need for VTE prevention solutions.

Read More On The Venous Thromboembolism Market Report 2023 – https://www.thebusinessresearchcompany.com/report/venous-thromboembolism-global-market-report

Innovative Anticoagulant Developments

Focus on Advancements

Major players in the VTE market are actively engaged in the development of innovative anticoagulant drugs to enhance their market presence. For example, Anthos Therapeutics received FDA approval for its abelacimab anticoagulant medicine, a fully human monoclonal antibody aimed at preventing stroke and systemic embolism in patients with atrial fibrillation. This development signifies a move towards more effective anticoagulation therapies.

Strategic Acquisitions in the Sector

In the pursuit of expanding thrombectomy portfolios, companies are strategically acquiring entities specializing in VTE solutions. In July 2021, Surmodics Inc. acquired Vetex Medical Limited, a move aimed at bolstering its thrombectomy portfolio by incorporating the ReVene Thrombectomy Catheter. Vetex Medical, an Ireland-based company, focuses on manufacturing devices for venous thromboembolism and related conditions.

Market Segmentation and Strategic Focus

Insights into Market Segmentation

The VTE market is segmented based on the type of thromboembolic events, including Deep Vein Thrombosis (DVT), Pulmonary Embolism, and other types. Treatment options encompass anti-clotting medications, mechanical devices, thrombolytic therapy, and other evolving therapies. Various end-users include hospitals, homecare settings, specialty centers, and other healthcare facilities.

Request for A Sample Of  The Global Venous Thromboembolism Market Report:
https://www.thebusinessresearchcompany.com/sample_request?id=13001&type=smp

The Table Of Content For The Venous Thromboembolism Market Include:
1. Venous Thromboembolism Market Executive Summary
2. Venous Thromboembolism Market Segments
3. Venous Thromboembolism Market Size And Venous Thromboembolism Market Growth Rate
4. Key Venous Thromboembolism Market Trends
5. Major Venous Thromboembolism Market Drivers
……
25. Key Mergers And Acquisitions In The Venous Thromboembolism Market
26. Top Venous Thromboembolism Companies
27. Venous Thromboembolism Market Opportunities And Strategies
28. Venous Thromboembolism Market, Conclusions And Recommendations
29. Appendix

The Venous Thromboembolism Market Global Market Report 2023 covers regional data on key drivers, opportunities, and strategies for the seven major regions of the world that are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa. The report includes market size and forecast market shares for all the regions and countries with respect to the major players of the venous thromboembolism market. 

View More Reports Related To The Market –
Blood And Blood Components Global Market Report 2023
Blood Culture Tests Global Market Report 2023
Blood Collection Devices Global Market Report 2023

Contact us at:
The Business Research Company: https://www.thebusinessresearchcompany.com/ 
Americas +1 3156230293
Asia +44 2071930708
Europe +44 2071930708
Email us at [email protected]
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company 
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model